February 21, 2024Navinci and 2BScientific announce a strategic partnershipRead more about Navinci and 2BScientific announce a strategic partnership →
February 6, 2024Navinci joins Milner Therapeutics Institute Affiliated Company schemeRead more about Navinci joins Milner Therapeutics Institute Affiliated Company scheme →
February 5, 2024Assay database alert! E-cadherin/β-catenin addedRead more about Assay database alert! E-cadherin/β-catenin added →
January 29, 2024Navinci and Vector Labs announce strategic collaborationRead more about Navinci and Vector Labs announce strategic collaboration →
January 10, 2024Exciting news: Explore our dynamic assay database!Read more about Exciting news: Explore our dynamic assay database! →
November 24, 2023Navinci Diagnostics has partnered with Shanghai Universal BiotechRead more about Navinci Diagnostics has partnered with Shanghai Universal Biotech →
November 14, 2023Navinci and Research Instruments announce a strategic partnershipRead more about Navinci and Research Instruments announce a strategic partnership →
October 19, 2023Exciting Times in the World of Proteomics!Read more about Exciting Times in the World of Proteomics! →
October 10, 2023Expanding our reach – new distribution partnership in ItalyRead more about Expanding our reach – new distribution partnership in Italy →
October 2, 2023New Research Unveils p53 Aggregates’ Vital Role in Ovarian Cancer Prognosis and Treatment StrategiesRead more about New Research Unveils p53 Aggregates’ Vital Role in Ovarian Cancer Prognosis and Treatment Strategies →
September 20, 2023CICON-23, 20-23 September, Milan ItalyRead more about CICON-23, 20-23 September, Milan Italy →
September 15, 2023Expanding Your Options with NaveniLink™Read more about Expanding Your Options with NaveniLink™ →
